Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COLGATE PALMOLIVE CO Director's Dealing 2020

Aug 14, 2020

29956_dirs_2020-08-14_fd0fe6ba-4624-41d1-89e6-a121b3926153.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLGATE PALMOLIVE CO (CL)
CIK: 0000021665
Period of Report: 2020-08-12

Reporting Person: HUSTON JOHN J (SVP, Office of the Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-08-12 Common Stock M 38430.0000 $72.9900 Acquired 82988.0000 Direct
2020-08-12 Common Stock M 24100.0000 $73.0000 Acquired 107088.0000 Direct
2020-08-12 Common Stock M 22375.0000 $72.0000 Acquired 129463.0000 Direct
2020-08-12 Common Stock S 84905.0000 $77.1848 Disposed 44558.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-08-12 Stock Option (Right to Buy) $72.0000 M 22375.0000 Disposed 2022-06-16 Common Stock (22375.0000) Direct
2020-08-12 Stock Option (Right to Buy) $72.9900 M 38430.0000 Disposed 2022-09-08 Common Stock (38430.0000) Direct
2020-08-12 Stock Option (Right to Buy) $73.0000 M 24100.0000 Disposed 2023-09-25 Common Stock (24100.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 39383.0000 Indirect

Footnotes

F1: Exercise of stock options awarded under the issuer's incentive compensation plan.

F2: Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.

F3: Weighted average price, as these shares were sold in multiple transactions at prices ranging from $77.00 to $77.43, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: Option became exercisable in equal annual installments over two years beginning on the second anniversary of the June 16, 2016 grant date.

F5: Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date.

F6: Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.